Equillium (EQ) Non-Current Debt (2017 - 2023)
Equillium's (EQ) quarterly Non-Current Debt came in at $1.8 million in Q1 2023, down 81.95% year-on-year from $10.2 million in Q1 2022, and down 79.54% on a QoQ basis from $9.0 million in Q4 2022.
Equillium (EQ) Non-Current Debt (2017 - 2023) Analysis & Trends
Equillium (EQ) has 7 years of Non-Current Debt data on file, last reported at $1.8 million in Q1 2023.
- On a quarterly basis, Non-Current Debt fell 81.95% year-over-year to $1.8 million in Q1 2023; TTM through Mar 2023 was $1.8 million, a 81.95% decrease from a year earlier, with the FY2022 full-year figure at $9.0 million, down 11.76% from the prior year.
- Non-Current Debt for Q1 2023 stood at $1.8 million, down from $9.0 million in the prior quarter.
- Over the last five years, Non-Current Debt for EQ reached as high as $10.3 million in Q2 2022 and fell as low as $1.8 million in Q1 2023.
- Historically, Non-Current Debt has averaged $8.7 million across 5 years, with a median of $9.7 million in 2019.
- Across the five-year window, Non-Current Debt jumped 654.32% in 2019 and slumped 81.95% in 2023, its largest moves.
- Year by year, Non-Current Debt stood at $9.7 million in 2019, then advanced by 2.06% to $9.9 million in 2020, then climbed by 3.03% to $10.2 million in 2021, then fell by 11.76% to $9.0 million in 2022, then sank by 79.54% to $1.8 million in 2023.
- Per Business Quant data, the three most recent Non-Current Debt figures were $1.8 million in Q1 2023, $9.0 million in Q4 2022, and $4.6 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 105.94 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 842.92 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 9.00 Mn |
| Sep 30, 2022 | 4.62 Mn |
| Jun 30, 2022 | 10.30 Mn |
| Mar 31, 2022 | 10.20 Mn |
| Dec 31, 2021 | 10.20 Mn |
| Sep 30, 2021 | 8.87 Mn |
| Jun 30, 2021 | 10.10 Mn |
| Mar 31, 2021 | 7.51 Mn |
| Dec 31, 2020 | 9.90 Mn |
| Sep 30, 2020 | 9.04 Mn |
| Jun 30, 2020 | 9.81 Mn |
| Mar 31, 2020 | 9.75 Mn |
| Dec 31, 2019 | 9.70 Mn |
| Sep 30, 2019 | 9.62 Mn |
| Sep 30, 2018 | 1.27 Mn |
| Dec 31, 2017 | 1.06 Mn |